- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 4.79M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $443.38K |
| Capex restated | Q1 2026 · Mar 31, 2025 | $297.39K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$588.63K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.96M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $838.59K |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $805.71K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $1.01M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $3.31M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.19M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $9.58M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $11.5M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $16.4M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $15.12M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $17.31M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $16.03M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.27M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.33M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $19.31M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $19.21M |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.21M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.94M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.32M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.33M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.6M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$2.66M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | −$389.22K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | −$726.09K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $389.6K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $7.06M |